このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Haemonetics バランスシートの健全性
財務の健全性 基準チェック /26
Haemoneticsの総株主資本は$960.0M 、総負債は$807.8Mで、負債比率は84.1%となります。総資産と総負債はそれぞれ$2.2Bと$1.2Bです。 Haemoneticsの EBIT は$206.8Mで、利息カバレッジ比率10.6です。現金および短期投資は$180.5Mです。
主要情報
135.1%
負債資本比率
US$1.22b
負債
| インタレスト・カバレッジ・レシオ | 11.2x |
| 現金 | US$346.07m |
| エクイティ | US$905.37m |
| 負債合計 | US$1.64b |
| 総資産 | US$2.54b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Haemonetics (NYSE:HAE) Is Using Debt Reasonably Well
Sep 09
Is Haemonetics (NYSE:HAE) A Risky Investment?
Oct 24Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Jul 07Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Apr 06We Think Haemonetics (NYSE:HAE) Can Manage Its Debt With Ease
Jan 05Haemonetics (NYSE:HAE) Seems To Use Debt Rather Sparingly
Oct 04Recent updates
These 4 Measures Indicate That Haemonetics (NYSE:HAE) Is Using Debt Reasonably Well
Sep 09What You Can Learn From Haemonetics Corporation's (NYSE:HAE) P/E
Aug 14Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 46%?
Jul 18Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Jun 21Does Haemonetics (NYSE:HAE) Deserve A Spot On Your Watchlist?
Apr 30Haemonetics Corporation's (NYSE:HAE) Share Price Matching Investor Opinion
Apr 12Haemonetics Corporation (NYSE:HAE) Shares Could Be 35% Below Their Intrinsic Value Estimate
Mar 07Haemonetics Corporation: Improved Performance, Another Bolt-On Deal
Mar 06The Strong Earnings Posted By Haemonetics (NYSE:HAE) Are A Good Indication Of The Strength Of The Business
Feb 15The Price Is Right For Haemonetics Corporation (NYSE:HAE)
Jan 01Haemonetics: Solid Performance Of This Blood Play
Nov 22Here's Why We Think Haemonetics (NYSE:HAE) Might Deserve Your Attention Today
Nov 14Is Haemonetics (NYSE:HAE) A Risky Investment?
Oct 24Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment
Oct 13Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains
Aug 09Here's Why Haemonetics (NYSE:HAE) Has Caught The Eye Of Investors
Aug 09An Intrinsic Calculation For Haemonetics Corporation (NYSE:HAE) Suggests It's 48% Undervalued
Jul 25Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Jul 07Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Apr 06Is There An Opportunity With Haemonetics Corporation's (NYSE:HAE) 46% Undervaluation?
Mar 19Haemonetics Executing Well, But Valuation Dogged By Concerns About A Large Customer
Feb 16Haemonetics: Earnings Rate Of Change Justifies High Multiples
Feb 01We Think Haemonetics (NYSE:HAE) Can Manage Its Debt With Ease
Jan 05Is There An Opportunity With Haemonetics Corporation's (NYSE:HAE) 36% Undervaluation?
Dec 15Haemonetics Q2 2023 Earnings Preview
Nov 04Haemonetics (NYSE:HAE) Seems To Use Debt Rather Sparingly
Oct 04Haemonetics: Plasma Thesis Continues To Play Out, Reiterate Buy
Sep 06Haemonetics reaches new 52-week high; shares up 41% YTD
Aug 24Haemonetics reports Q2 earnings beat; raises FY22 guidance
Aug 10A Look At The Intrinsic Value Of Haemonetics Corporation (NYSE:HAE)
Aug 10Here's Why Haemonetics (NYSE:HAE) Can Manage Its Debt Responsibly
Jul 03Haemonetics: Upside Case Hinges On Blood Plasma Collection Market
Jun 11財務状況分析
短期負債: HAEの 短期資産 ( $768.9M ) が 短期負債 ( $300.4M ) を超えています。
長期負債: HAEの短期資産 ( $768.9M ) は 長期負債 ( $935.2M ) をカバーしていません。
デット・ツー・エクイティの歴史と分析
負債レベル: HAEの 純負債対資本比率 ( 65.3% ) は 高い と見なされます。
負債の削減: HAEの負債対資本比率は、過去 5 年間で53.2%から84.1%に増加しました。
債務返済能力: HAEの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 11.1% )。
インタレストカバレッジ: HAEの負債に対する 利息支払い は EBIT ( 10.6 x coverage) によって 十分にカバーされています。